Hughes-Wilson Alexandra has filed 27 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 183750 shares of Mereo BioPharma Group plc ($MREO) on February 01, 2026.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | A | Share Options (Right to buy) | 183750 | $0.00 | 183,750.0000 | 799,947,013 | 9999.99% | 0.02% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | A | Share Options (Right to buy) | 195000 | $0.00 | 195,000.0000 | 799,947,013 | 9999.99% | 0.02% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | A | Share Options (Right to buy) | 61250 | $0.00 | 61,250.0000 | 799,947,013 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | A | Share Options (Right to buy) | 154000 | $0.00 | 154,000.0000 | 739,624,264 | 9999.99% | 0.02% |
| Sept. 13, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 84008 | $4.22 | 50,475.0000 | 770,146,589 | 62.47% | 0.01% |
| Sept. 13, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 16304 | $4.22 | 134,483.0000 | 770,146,589 | 10.81% | 0.00% |
| Sept. 12, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 40029 | $4.47 | 150,787.0000 | 770,146,589 | 20.98% | 0.01% |
| Sept. 12, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 7769 | $4.47 | 190,816.0000 | 770,146,589 | 3.91% | 0.00% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Performance Based Restricted Stock Unit | 40000 | $0.00 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Share Options (Right to buy) | 93333 | $1.40 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Share Options (Right to buy) | 75000 | $1.01 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 40000 | $0.00 | 74,548.0000 | 770,146,589 | 115.78% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 93333 | $1.40 | 167,881.0000 | 770,146,589 | 125.20% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 75000 | $1.01 | 242,881.0000 | 770,146,589 | 44.67% | 0.01% |
| June 25, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 10134 | $3.69 | 57,516.0000 | 659,453,921 | 14.98% | 0.00% |
| June 26, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 22968 | $3.39 | 34,548.0000 | 659,453,921 | 39.93% | 0.00% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Performance Based Restricted Stock Unit | 60000 | $0.00 | 40,000.0000 | 659,453,921 | 0.00% | 0.01% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 60000 | $0.00 | 67,650.0000 | 659,453,921 | 784.31% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | F | American Depositary Shares representing Ordinary Shares | 42983 | $1.40 | 7,650.0000 | 659,453,921 | 84.89% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 50082 | $2.94 | 32,568.0000 | 659,453,921 | 60.60% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | F | American Depositary Shares representing Ordinary Shares | 24918 | $1.01 | 7,650.0000 | 659,453,921 | 76.51% | 0.00% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Share Options (Right to buy) | 93333 | $1.40 | 0.0000 | 659,453,921 | 100.00% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | Share Options (Right to buy) | 75000 | $1.01 | 0.0000 | 659,453,921 | 100.00% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 75000 | $1.01 | 82,650.0000 | 659,453,921 | 980.39% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | S | American Depositary Shares representing Ordinary Shares | 50350 | $2.99 | 58,633.0000 | 659,453,921 | 46.20% | 0.01% |
| May 22, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | M | American Depositary Shares representing Ordinary Shares | 93333 | $1.40 | 100,983.0000 | 659,453,921 | 1220.04% | 0.01% |
| Jan. 25, 2024 | Mereo BioPharma Group plc | $MREO | Hughes-Wilson Alexandra | See Remarks | A | Share Options (Right to buy) | 196000 | $0.00 | 196,000.0000 | 659,453,921 | 9999.99% | 0.03% |